Hans Schreiber to Receptors, Interleukin-2
This is a "connection" page, showing publications Hans Schreiber has written about Receptors, Interleukin-2.
Connection Strength
0.022
-
Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med. 2005 Mar 07; 201(5):779-91.
Score: 0.016
-
In vivo administration of anti-CD3 prevents malignant progressor tumor growth. Science. 1988 Oct 28; 242(4878):569-71.
Score: 0.005